Year: 2019
The agents of discovery: patenting and licensing ideas from bench to bedside
| Dec 12, 2019Meet St. Jude’s tech transfer experts who patent and license researchers’ basic science discoveries to help patients worldwide.
Learn moreFor new ideas and collaboration, St. Jude Global hosts neuro-oncology training seminar
| Dec 5, 2019St. Jude Global Academy hosted a neuro-oncology seminar to generate new ideas for high-impact interventions and share experiences. Read more.
Learn moreEnding the HIV epidemic: A national plan to reduce HIV infections
| Nov 27, 2019Ending the HIV Epidemic is a bold plan to reduce HIV infections by 90 percent nationally. On a local level, St. Jude aims to have no new HIV cases by 2030.
Learn moreSmithsonian honors St. Jude visionaries for ‘bubble boy’ cure
| Nov 19, 2019Read how St. Jude researchers and clinicians used gene therapy to cure the diabolical bubble boy disease.
Learn moreProteins: Playing with molecular rubber duckies
| Nov 18, 2019Are you a match? Read how this molecule’s affinity to proteins can change according to water.
Learn moreNew analytical technique reveals the subtle genetic differences among cancer cells
| Nov 12, 2019Sequencing data gives insights into what’s going on in a cell. It’s a lot of information. Read how scientists are finding ways to cut through the information and find causes for disease.
Learn moreGenetic sequencing: How do we put out the fires of genetically driven cancers?
| Nov 8, 2019Too much of a good thing? Read how genetic sequencing offers insights into the causes of some cancers, but the avalance of data creates a new set of issues.
Learn moreSurvivorship studies dig in on data
| Nov 6, 2019Read how cancer survivorship research reveals more about the late effects of treatment on children – and how the data can paint a more complete picture.
Learn moreHaving those critical conversations about fertility after cancer
| Nov 5, 2019As clinicians learn more about the late effects of pediatric cancer treatments, these important discussions with patients are changing.
Learn moreResearch homes in on drug to dampen inflammation fueling life-threatening immune disorder
| Nov 1, 2019Researchers have promising information that ruxolitinib may help treat a devastating auto-immune disorder.
Learn more